Literature DB >> 25183740

Late erosion of Amplatzer septal occluder device resulting in cardiac tamponade.

Vakhtang Tchantchaleishvili1, Amber L Melvin2, Frederick S Ling3, Peter A Knight2.   

Abstract

Transcatheter device closure of atrial septal defects (ASDs) is a minimally invasive technique that offers an alternative to conventional surgical repair. There are risks imposed by this technique; however, they compare favourably with risks of surgical closure. Here, we present a case of a 59-year old male with late erosion of an Amplatzer septal occluder device resulting in cardiac tamponade 5 years after device placement. To the best of our knowledge, cardiac tamponade this late after device placement has not yet been reported. Septal occlusion device erosion remains a major issue among the risks imposed by device closure of an ASD. More data are needed to better understand its true causes and possible solutions.
© The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Atrial septal defects; Cardiac catheterization; Cardiac tamponade

Mesh:

Year:  2014        PMID: 25183740     DOI: 10.1093/icvts/ivu271

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  3 in total

1.  Delayed recurrent pleuropericardial effusions following atrial septal defect closure with Amplatzer septal occluder device: a case of postpericardiotomy syndrome?

Authors:  Grace Ghtk Kwok; Rachel Witts; Alessandra Frigiola
Journal:  BMJ Case Rep       Date:  2018-05-08

2.  A life-saving case of cardiopulmonary arrest with cardiac tamponade caused by erosion 6 years after percutaneous atrial septal defect closure: a case report.

Authors:  Takuma Kobayashi; Taiji Watanabe; Haruka Fu; Okada Yohei; Tomoyuki Goto
Journal:  J Cardiothorac Surg       Date:  2021-05-21       Impact factor: 1.637

3.  Initial Experience with the Nit-Occlud ASD-R: Short-Term Results.

Authors:  Mustafa Orhan Bulut; Ilker Kemal Yucel; Mehmet Kucuk; Sevket Balli; Evic Zeynep Basar; Ahmet Celebi
Journal:  Pediatr Cardiol       Date:  2016-06-09       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.